HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Okazawa Selected Research

polyglutamine-binding protein 1

11/2021Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation.
10/2018The intellectual disability gene PQBP1 rescues Alzheimer's disease pathology.
9/2005PQBP-1 is expressed predominantly in the central nervous system during development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Okazawa Research Topics

Disease

11Alzheimer Disease (Alzheimer's Disease)
10/2021 - 03/2009
10Huntington Disease (Huntington's Disease)
04/2021 - 10/2003
9Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 11/2005
8Intellectual Disability (Idiocy)
01/2020 - 09/2005
8Spinocerebellar Ataxias (Spinocerebellar Ataxia)
08/2017 - 05/2002
5Cognitive Dysfunction
11/2021 - 01/2016
3Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
12/2021 - 01/2018
3Necrosis
04/2021 - 01/2020
3Microcephaly
10/2018 - 09/2005
3X-Linked Mental Retardation (Mental Retardation, X Linked)
04/2014 - 04/2012
2Inflammation (Inflammations)
11/2021 - 01/2015
1Pathologic Processes
06/2022
1Schizophrenia (Dementia Praecox)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
11/2021
1Bites and Stings (Sting)
11/2021
1Carotid Stenosis (Carotid Artery Stenosis)
01/2019
1Classical Lissencephalies and Subcortical Band Heterotopias
01/2019
1Lissencephaly
01/2019
1Frontotemporal Dementia (Semantic Dementia)
01/2018
1Disease Progression
01/2015
1Postmortem Changes (Adipocere)
01/2011
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
11/2010
1Learning Disabilities (Learning Disability)
10/2010
1Seizures (Absence Seizure)
11/2005

Drug/Important Bio-Agent (IBA)

13polyglutamineIBA
06/2022 - 05/2002
12Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2003
8HMGB1 Protein (HMG1)IBA
12/2021 - 11/2008
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2008
4Ataxin-1IBA
01/2015 - 04/2003
3polyglutamine-binding protein 1IBA
11/2021 - 09/2005
3Amyloid (Amyloid Fibrils)IBA
04/2021 - 01/2018
3PhosphoproteinsIBA
04/2021 - 01/2011
3Amyloid beta-PeptidesIBA
01/2020 - 07/2015
3Carrier Proteins (Binding Protein)IBA
01/2020 - 11/2009
2AntibodiesIBA
01/2022 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2Myristoylated Alanine-Rich C Kinase SubstrateIBA
01/2020 - 07/2018
2Nuclear Proteins (Protein, Nuclear)IBA
01/2015 - 11/2011
2RNA (Ribonucleic Acid)IBA
01/2013 - 01/2012
2HMGB ProteinsIBA
01/2012 - 11/2011
2Mutant Proteins (Protein, Mutant)IBA
01/2012 - 07/2010
2ProteomeIBA
11/2011 - 01/2011
1Intrinsically Disordered ProteinsIBA
06/2022
1AutoantibodiesIBA
01/2022
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2022
1cyclic guanosine monophosphate-adenosine monophosphateIBA
11/2021
1InterferonsIBA
11/2021
1TamoxifenFDA LinkGeneric
11/2021
1tau Proteins (tau Protein)IBA
11/2021
1Complementary DNA (cDNA)IBA
11/2021
1Serine (L-Serine)FDA Link
01/2020
1Cadherins (E-Cadherin)IBA
01/2019
1Cell Cycle ProteinsIBA
10/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1ProgranulinsIBA
01/2018
1Protein AggregatesIBA
01/2017
1Small Molecule LibrariesIBA
09/2016
1Histidine (L-Histidine)FDA Link
09/2016
1Pharmaceutical PreparationsIBA
09/2016
1Monoclonal AntibodiesIBA
01/2016
1PhosphopeptidesIBA
01/2015
1Receptor for Advanced Glycation End ProductsIBA
01/2015
1Mitochondrial DNA (mtDNA)IBA
01/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015
1Eosine Yellowish-(YS) (Eosin)IBA
08/2013
1Hematoxylin (Haematoxylon)IBA
08/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Ataxin-7IBA
03/2012
1TATA-Box Binding Protein (TATA-Binding Protein)IBA
03/2012
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2011
1Antisense OligonucleotidesIBA
11/2010
1VorinostatFDA Link
10/2010
1Histone Deacetylase InhibitorsIBA
10/2010
1Mitochondrial Proteins (Mitochondrial Protein)IBA
07/2008
1Small Interfering RNA (siRNA)IBA
01/2007
1Kainic Acid (Kainate)IBA
11/2005
1Cytochromes c (Cytochrome c)IBA
11/2005
1Caspase 3 (Caspase-3)IBA
11/2005
1Histone Deacetylases (Histone Deacetylase)IBA
10/2003

Therapy/Procedure

5Therapeutics
12/2021 - 01/2017
1Subcutaneous Injections
01/2016